Covidien (NYSE:COV) acquired ventilator-maker Newport Medical Instruments for $108 million in a deal that is due to close in the second quarter.The firm said that Newport Medical will be merged with its Medical Devices segment.Covidien (NYSE:COV) has potential upside of 10.9% based on a current price of $53.61 and an average consensus analyst price target of $59.47.